Design, Synthesis, and Biological Evaluation of 6″-Modified Apramycin Derivatives to Overcome Aminoglycoside Resistance.

Shapovalova KS, Zatonsky GV, Razumova EA, Dagaev ND, Lukianov DA, Grammatikova NE, Tikhomirov AS, Shchekotikhin AE.

Open source

DOI: 10.3390/pharmaceutics17121583
Published: 2025-12-08
Container: Pharmaceutics
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics17121583,
  title = {Design, Synthesis, and Biological Evaluation of 6″-Modified Apramycin Derivatives to Overcome Aminoglycoside Resistance.},
  author = {Shapovalova KS and  Zatonsky GV and  Razumova EA and  Dagaev ND and  Lukianov DA and  Grammatikova NE and  Tikhomirov AS and  Shchekotikhin AE.},
  year = {2025},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics17121583},
  url = {https://doi.org/10.3390/pharmaceutics17121583}
}

RIS

TY  - JOUR
TI  - Design, Synthesis, and Biological Evaluation of 6″-Modified Apramycin Derivatives to Overcome Aminoglycoside Resistance.
AU  - Shapovalova KS
AU  -  Zatonsky GV
AU  -  Razumova EA
AU  -  Dagaev ND
AU  -  Lukianov DA
AU  -  Grammatikova NE
AU  -  Tikhomirov AS
AU  -  Shchekotikhin AE.
PY  - 2025
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics17121583
UR  - https://doi.org/10.3390/pharmaceutics17121583
ER  -

APA

KS, S., GV, Z., EA, R., ND, D., DA, L., NE, G., AS, T., & AE., S. (2025). Design, Synthesis, and Biological Evaluation of 6″-Modified Apramycin Derivatives to Overcome Aminoglycoside Resistance.. Pharmaceutics. https://doi.org/10.3390/pharmaceutics17121583

Source records

europe-pmc · retrieved 2026-09-26T01:16:59.224Z
doaj · retrieved 2026-09-26T01:16:59.247Z